Biomarkers for Gastric Cancer Screening and Early Diagnosis.

ABSTRACT: Gastric cancer is one of the most common cancers worldwide, with a bad prognosis associated with late-stage diagnosis, significantly decreasing the overall survival. This highlights the importance of early detection to improve the clinical course of these patients. Although screening programs, based on endoscopic or radiologic approaches, have been useful in countries with high incidence, they are not cost-effective in low-incidence populations as a massive screening strategy. Additionally, current biomarkers used in daily routine are not specific and sensitive enough, and most of them are obtained invasively. Thus, it is imperative to discover new noninvasive biomarkers able to diagnose early-stage gastric cancer. In this context, liquid biopsy is a promising strategy. In this review, we

SUBMITTER: Herrera-Pariente C 

PROVIDER: S-EPMC8533304 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature